Financial reports
Current reports
8-K
Other Events
25 Apr 24
8-K
Reports on growing clinical data supporting its neurostimulation technology and progress advancing its new Gen-3 HALO™ Clarity Virtual Clinic model
11 Apr 24
8-K
Submission of Matters to a Vote of Security Holders
20 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
13 Nov 23
8-K
Departure of Directors or Certain Officers
28 Sep 23
8-K
Entry into a Material Definitive Agreement
2 Jun 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
16 May 23
8-K
Changes in Registrant's Certifying Accountant
3 Oct 22
8-K/A
Nexalin Technology, Inc. Announces Closing of $9.6 Million Initial Public Offering
20 Sep 22
8-K
Nexalin Technology, Inc. Announces Closing of $9.6 Million Initial Public Offering
20 Sep 22
Registration and prospectus
S-3
Shelf registration
15 Apr 24
424B4
Prospectus supplement with pricing info
19 Sep 22
S-1/A
IPO registration (amended)
15 Sep 22
S-1/A
IPO registration (amended)
15 Sep 22
8-A12B
Registration of securities on exchange
15 Sep 22
S-1/A
IPO registration (amended)
24 Aug 22
S-1/A
IPO registration (amended)
31 May 22
S-1/A
IPO registration (amended)
16 May 22
S-1/A
IPO registration (amended)
27 Apr 22
S-1/A
IPO registration (amended)
8 Apr 22
Proxies
Other
CERT
Certification of approval for exchange listing
16 Sep 22
EFFECT
Notice of effectiveness
16 Sep 22
CORRESP
Correspondence with SEC
12 Sep 22
CORRESP
Correspondence with SEC
12 Sep 22
CORRESP
Correspondence with SEC
31 May 22
CORRESP
Correspondence with SEC
16 May 22
UPLOAD
Letter from SEC
6 May 22
CORRESP
Correspondence with SEC
27 Apr 22
UPLOAD
Letter from SEC
22 Apr 22
CORRESP
Correspondence with SEC
8 Apr 22